AcouSort
2.28 SEK
-4.60 %
Less than 1K followers
ACOU
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-4.60 %
-11.97 %
-31.12 %
-26.92 %
-79.27 %
-80.60 %
-87.26 %
-88.67 %
-71.11 %
AcouSort operates in the medical technology sector. The company has a developed platform technology focused on acoustophoresis, which uses ultrasound to separate and analyze the compositions of biological cells. The technology is mainly used in the analysis of cancer cases and sepsis (blood poisoning). A large part of the research is carried out in collaboration with other players in Life Science. The company was established in 2010 and has its headquarters in Lund.
Read moreMarket cap
48.25M SEK
Turnover
96.37K SEK
Revenue
4.74M
EBIT %
-340.3 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
25/2
2026
Annual report '25
All
Press releases
3rd party
ShowingAll content types
Stefan Blomsterberg elected new Chairman of the Board of AcouSort
Redeye: AcouSort (Q3 review) - New collaboration alongside progress in existing one
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools